MAP Pharmaceuticals, Inc.(MAPP)- NASDAQ
MAPP is defunct since March 4, 2013. acquired by a private company
From other sites
Company Description
MAP Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing new therapies to address undermet patient needs in neurology. The Company is developing LEVADEX®, an orally inhaled investigational drug for the potential acute treatment of migraine. The U.S. Food and... More
Sector: Healthcare
Industry: Drug Manufacturers - Other
Country: United States